High Velocity Critical Event Management in action: Real-world examples and best practices
The webinar demonstrates how HV CEM can be used to effectively manage and mitigate real-world risks and crises across various industries.
Industry analyst reports
Keep up to date on recent Everbridge news, events, and content, including from our recent thought leadership events and articles.
Report recognition
Below are reports* † in which we’ve received recognition. In addition to those published here, we are also excited to be included in:
- Gartner® Hype Cycle™ for Consumer Engagement & Experience in Healthcare and Life Sciences, July 31st 2023
- Gartner® Hype Cycle™ for Public Safety and Law Enforcement, July 25th 2023
- Gartner® Hype Cycle™ for Cyber Risk Management, July 25th 2023
- Gartner® Hype Cycle™ for Real-Time Health System Technologies, July 17th 2023
- Gartner® Hype Cycle™ for Site Reliability Engineering, July 17th 2023
- Gartner® Hype Cycle™ for I&O Automation, July 14th 2023
- Gartner® Hype Cycle™ for ITSM, July 14th 2023
- Gartner® Hype Cycle™ for Monitoring and Observability, July 10th 2023
- The Forrester Wave™: Process-Centric AI For IT Operations (AIOps), Q2 2023
- Forrester: The External Threat Intelligence Service Providers Landscape, Q1 2023
- Forrester: The Process-Centric AIOps Landscape, Q1 2023
- Forrester: The State of Threat Intelligence, Q2 2023
- Verdantix Tech Roadmap: EHS Technologies, March 2023
- Verdantix Strategic Focus: Protecting Workers from Climate Risk, February 2023
- Verdantix Tech Roadmap: Climate Risk Digital Solutions, January 2023
- Verdantix Smart Innovators: ESG Reporting and Data Management Software, January 2023
- Verdantix Green Quadrant: Integrated Smart Security Software, Q1 2023
8 Steps to enterprise resilience: Developing effective business continuity plans
Apply an 8-step framework for building enterprise resilience through effective business continuity planning. Identify risks, set objectives, and adapt to challenges.
Navigating the expanding risk zone: The 2026 global risk and resilience outlook
The 2026 Global Risk and Resilience Outlook is based on customer research. This webinar emphasizes proactive strategies, evolving technologies to build resilience.
Everbridge supports healing and emergency response at Hackensack Meridian Health
Hackensack Meridian Health, guided by Scott Skrivanek, Network Director of Emergency Management, uses Everbridge to create a safer, quieter, and more healing-focused environment across its 18 hospitals and 600 locations. By streamlining critical communications for medical emergencies and unexpected events like earthquakes, Everbridge helps protect over 36,000 employees and thousands of patients daily, ensuring swift responses and improved patient care. Discover how this technology fosters both safety and healing.
The 4 pillars of AI in managing high-stakes critical events
Learn about the transformative role of AI in managing critical events through four pillars: direction, speed, accuracy, and improvement.
Redefining business continuity: From static plans to dynamic resilience
Learn how to transform static continuity plans into dynamic, tech-enabled resilience strategies in this free Everbridge webinar for risk and resilience professionals.
*Forrester reports are available to Forrester subscribers or for purchase.
†Gartner reports are available for Gartner subscribers only
†GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
†Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
